ArticleFrontiers in immunology2024

Bispecific killer cell engagers employing species cross-reactive NKG2D binders redirect human and murine lymphocytes to ErbB2/HER2-positive malignancies.

Jordi Pfeifer Serrahima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.